mRNA Influenza Vaccines Market Size, Share & Industry Analysis, By Product Type (Standalone and Combination Vaccines), By Indication (Seasonal Influenza, Pre-pandemic/Pandemic Influenza, and Broad-Spectrum/Universal Influenza), By Technology (Conventional Non-Replicating mRNA, Self-Amplifying mRNA, and Trans-Amplifying RNA), By Valency (Monovalent, Trivalent, and Quadrivalent), By Age Group (Pediatric, 18-49, 50-64, and 65+ Years), By Distribution Channel (Government Health Programs, Hospitals & Vaccination Clinics, and Retail Pharmacies & Drug Stores), and Regional Forecast, 2026-2034

Last Updated: September 17, 2026 | Format: PDF | Report ID: FBI119161

Buy Now

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2021-2024
Growth Rate	CAGR of 70.99% from 2026 to 2034
Unit	Value (USD Million)
Segmentation	By Product Type, Indication, Technology, Valency, Age Group, Distribution Channel, and Region
By Product Type	Standalone mRNA Influenza Vaccines Combination mRNA Influenza Vaccines Others
By Indication	Seasonal Influenza Pre-pandemic/Pandemic Influenza Broad-Spectrum/Universal Influenza Others
By Technology	Conventional Non-replicating mRNA Self-Amplifying mRNA Trans-Amplifying/Replicon RNA Others
By Valency	Monovalent Trivalent Quadrivalent Others
By Age Group	Pediatric (<18 Years) 18–49 Years 50–64 Years ≥65 Years
By Distribution Channel	Government & Public Health Programs Hospitals & Vaccination Clinics Retail Pharmacies & Drug Stores Others
By Region	North America (By Product Type, Indication, Technology, Valency, Age Group, Distribution Channel, and Country) U.S. Canada Europe (By Product Type, Indication, Technology, Valency, Age Group, Distribution Channel, and Country/Sub-region) Germany U.K. France Spain Italy Scandinavia Rest of Europe Asia Pacific (By Product Type, Indication, Technology, Valency, Age Group, Distribution Channel, and Country/Sub-region) China Japan India Australia Southeast Asia Rest of Asia Pacific Latin America (By Product Type, Indication, Technology, Valency, Age Group, Distribution Channel, and Country/Sub-region) Brazil Mexico Rest of Latin America Middle East & Africa (By Product Type, Indication, Technology, Valency, Age Group, Distribution Channel, and Country/Sub-region) GCC South Africa Rest of the Middle East & Africa